GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: PRGO
Buy $170

Perrigo Company (NYSE: PRGO) upgraded to Buy with price target $170 by Argus

Thursday,  Dec 10, 2015  8:25 AM ET by Betsy O'Brien Harrison

Argus upgraded Perrigo Company (NYSE: PRGO) to Buy with price
target $170. Previously Argus upgraded to Perrigo Company (NYSE: PRGO) to Hold on 04/10/2015, when the stock price was $199.90.

Perrigo Company, is the nations largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products and also manufactures store brand nutritional products. Store brand products are sold by national and regional supermarket, drugstore and mass merchandise chains under their own labels and compete with nationally advertised brands. The Company's products include analgesics, cough and cold remedies, antacids, laxatives, feminine hygiene and smoking cessation products, and vitamins, nutritional supplements and nutritional drinks.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy